Sigyn Therapeutics, Inc. (OTCMKTS:SIGY) Stock Short Interest Report for October

Sigyn Therapeutics, Inc. (OTCMKTS:SIGY) was the target of a large increase in short interest during the month of October. As of October 15th, there was short interest totaling 1,994 shares. Approximately 0.4% of the shares of the company are sold short. Based on an average daily volume of 13,955 shares, the days-to-cover ratio is presently 0.1 days.

Sigyn Therapeutics Price Performance

Shares of OTCMKTS:SIGY opened at $0.03 on Monday. The business’s 50 day moving average price is $0.03 and its 200-day moving average price is $0.12. The firm has a market capitalization of $70,612.00, a price-to-earnings ratio of -0.01 and a beta of 0.15. Sigyn Therapeutics has a 1 year low of $0.01 and a 1 year high of $2.00.

Sigyn Therapeutics Company Profile

Sigyn Therapeutics, Inc is a biotechnology and medical device company focused on developing therapeutic solutions for cancer and pathogen-associated diseases. The company’s primary technology is designed to address conditions in which harmful pathogens and excessive inflammatory signaling contribute to disease progression.

Its lead product candidate, Sigyn Therapy, is an extracorporeal blood-purification technology intended to remove circulating pathogens and inflammatory cytokines from a patient’s blood.